potassium chloride 0.15% w/v & glucose 5% w/v solution for infusion
fresenius kabi limited - potassium chloride; glucose monohydrate - solution for infusion - 0.15 + 5 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates - blood substitutes and perfusion solutions; electrolytes with carbohydrates - prevention and treatment of potassium depletion and/or hypokalaemia in cases where supply of water and carbohydrates is required due to either restriction of the intake of fluids and electrolytes or depletion by normal routes
potassium chloride 0.3% w/v & glucose 5% w/v solution for infusion
fresenius kabi limited - potassium chloride; glucose monohydrate - solution for infusion - 0.3 + 5 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates - blood substitutes and perfusion solutions; electrolytes with carbohydrates - prevention and treatment of potassium depletion and/or hypokalaemia in cases where supply of water and carbohydrates is required due to either restriction of the intake of fluids and electrolytes or depletion by normal routes.
lipertance tablets film-coated
les laboratoires servier industrie 905 - atorvastatin (atorvastatin calcium trihydrate), perindopril arginine, amlodipine (amlodipine besilate) - tablets film-coated - 20mg+ 10mg+ 5mg
streptomycin sulfate powder for solution for i/m injection
"sintez" ojsc - streptomycin (streptomycin sulfate) - powder for solution for i/m injection - 1000mg
vyvanse 50 mg
medison pharma ltd - lisdexamfetamine dimesylate - capsules - lisdexamfetamine dimesylate 50 mg - lisdexamfetamine - vyvanse is a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in patients ages 6 years and above.vyvanse is indicated for the treatment of moderate to severe binge eating disorder (bed) for patient over 18 years.limitation of use:vyvanse is not indicated or recommended for weight loss. use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. the safety and effectiveness of vyvanse for the treatment of obesity have not been established
dermostamin gel
trima israel pharmaceutical products maabarot ltd - dimetindene maleate - gel - dimetindene maleate 0.1 %w/w - dimetindene - urticaria, pruritis, dermatoses, burns, insect bites, allergic dermatitis and eczema.
licopid tablets
peptek jsc - glucosamine muramyl dipeptide - tablets - 1mg
advagraf capsules prolonged-release
astellas ireland co. ltd. - tacrolimus - capsules prolonged-release - 3mg
afobazol tablets
pharmstandard-leksredstva jsc - fabomotizole (fabomotizole dihydrochloride) - tablets - 10mg
nadixa 1%
مستودع أدوية ابن رشد - ibn rushd drug store - nadifloxacin 1 % - 1%